ANTABIO
Edit

ANTABIO

http://www.antabio.com/
Last activity: 12.12.2023
Categories: MedTechProductFastDrugDevelopmentClinicAdTechManagementHealthTechFinTech
Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. Two of Antabio’s programs have received Wellcome Trust Seeding Drug Discovery Awards to date: [i] a novel, safe and efficacious inhibitor of bacterial metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections and [ii] a first-in-class inhibitor of Pseudomonas virulence to be co-administered with standard-of-care antibiotics for the long-term management of chronic respiratory infections. The company’s lead product is expected to enter the clinic in 2019 with a fast track to anticipated marketing approval. Antabio has built a best in class, international team of experts in the field and is currently seeking to raise additional funds to progress its pipeline up to the next value inflection point. Our company is also looking to in-license additional assets focused on Gram-negative antibiotic resistant therapies. Please visit www.antabio.com and follow us on Twitter @antabio
Followers
633
Mentions
5
Location: France, Occitania, Labège
Employees: 11-50
Total raised: $63.53M
Founded date: 2009

Investors 4

Funding Rounds 5

DateSeriesAmountInvestors
12.12.2023Series B$27M-
02.01.2020-$4.4MCARB-X
12.07.2018Series A$14.62M-
17.10.2017Series A$8.61M-
08.08.2017Grant$8.9MCARB-X

Mentions in press and media 5

DateTitleDescriptionSource
12.12.2023Antabio Raises €25M in Series B FundingAntabio, a Labège, France-based clinical stage biopharmaceutical company, raised €25M in Series B fu...finsmes.co...
25.05.2023Antabio Announces First Subjects Dosed in Phase 1 Clinical T.../EIN News/ -- MEM-ANT3310 has the potential to become the next standard of care for life-threatening...einpresswi...
02.01.2020Top tech startup news for today, Thursday, January 2, 2020 –...Happy New Year! Welcome to 2010. Below is our first top startup new stories of the year 2020. Germa...techstartu...
02.01.2020French biotech startup Antabio receives $4.4 million from CA...Antabion, a Labege, France-based biotech startup announced today it has been awarded up to $4.4 mill...techstartu...
12.07.2018Biopharma Company Antabio Raises Additional €5.2M; Closes €1...Antabio SAS, a Labège, France-based biopharmaceutical company developing novel antibacterial treatme...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In